VivoSeq
Other

Concussion

17

Pipeline Programs

6

Active Trials

8

Companies Involved

Concussion is an emerging landscape with 17 programs across 8 companies. The most active players are COMPASS Pathways, Viatris Specialty LLC, Micelle BioPharma Inc. 4 therapies are approved.

Pipeline Metrics

Competitive Density

46/100

Pipeline Velocity

6/100

Mech. Concentration

10/100

Completion Rate

79/100

Attrition Rate

14/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

22

clinical trials

Completed11 · 50%
Recruiting5 · 23%
Terminated2 · 9%
Unknown status2 · 9%
Withdrawn1 · 5%
Not yet recruiting1 · 5%

Trial Activity

22 trials

BCAAs in Concussion 2.0
Recruiting··Phase 2·NCT06829498·150 enrolled
Ghrelin (OXE--103) for Acute Concussion Management
Completed··Phase 2·NCT04558346·23 enrolled
BCAA Supplementation for Concussion
Completed··Phase 2·NCT01860404·42 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)